DIALOGFARMA, OOO, Moscow

Accounting reports

Previously

Name	DIALOGFARMA, OOO
INN	7722581269
KPP	772201001
OGRN	1067746760751
OKPO	96036281
Address	109029, G.moskva, pr-d Avtomobil'nyy, d. D.6
Phone	+7 (495) 974-70-00

Extract from EGRUL $12 (€10)

Last name, first name & patronymic of the General Director

List of founders

Position of the company

Licenses

Authorized capital

Branches

Complete structure of the extract

Download an extract from EGRUL

We guarantee to provide you with an actual
information extract

OKVED code	Type	Name of activity type
Data on types of economic activities DIALOGFARMA, OOO according to EGRUL
46.46	Core activity	Wholesale of pharmaceutical goods
21.20	Additional activity	Manufacturers of drugs and pharmaceuticals and medical products
21.20.1	Additional activity	Production of drugs
All types of activities
21.20.2	Additional activity	Production of materials used in medical applications

Registration information

Registration date	03.07.2006
Registering department	MEZHRAYONNAYA INSPEKTSIYA FEDERAL'NOY NALOGOVOY SLUZHBY N46 PO G. MOSKVE.

Description

DIALOGFARMA, OOO (Moscow; INN 7722581269) was registered on 3 Jul 2006. The company's authorized capital as of July 1, 2012 was 10000 rub.

Type of ownership of DIALOGFARMA, OOO - Limited liability companies.

Form of ownership of DIALOGFARMA, OOO - Property of foreign legal entities.

Principal activities of DIALOGFARMA, OOO: wholesale of pharmaceutical goods (46.46), manufacturers of drugs and pharmaceuticals and medical products (21.20), production of drugs (21.20.1).

Industry

21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
- 21.2 - The production of medicines and materials used in medical purposes
  - 21.20 - Manufacturers of drugs and pharmaceuticals and medical products
    - 21.20.1 - Production of drugs
    - 21.20.2 - Production of materials used in medical applications
46 - Wholesale trade (excluding motor vehicles)
- 46.4 - Wholesale of household goods
  - 46.46 - Wholesale of pharmaceutical goods

Economic indicators

2023

2022

Net profit (RAS) of DIALOGFARMA, OOO made up 0 RUB over 2022 compared to net loss of 1.04 million RUB over 2021, the company informed.

Sales profit made up 0 compared to net loss of 1.48 million RUB.

2021

Net loss (RAS) of DIALOGFARMA, OOO dropped over 2021 by 5.95% to 1.04 million RUB from 1.11 million RUB KAgent.Entities.Balance, the company informed.

Sales loss decreased by 1.01% to 1.48 million RUB from 1.49 million RUB.

2020

Net loss (RAS) of DIALOGFARMA, OOO increased by 10.23% to 1.11 million RUB from 1.01 million RUB over 2019, the company informed.

Sales loss grew by 4.56% to 1.49 million RUB from 1.43 million RUB.

2019

Net loss (RAS) of DIALOGFARMA, OOO dropped over 2019 by 34.91% to 1.01 million RUB from 1.55 million RUB KAgent.Entities.Balance, the company informed.

Sales loss matched the previous year’s result amounting to 1.43 million RUB.

2018

Net loss (RA) of DIALOGFARMA, OOO made up 1.55 million RUB over 2018 compared to net profit of 10.19 million RUB over 2017, the company informed.

Revenue decreased in the accounting period Infinity times to 0.00 thousand RUB from 37.88 million RUB in 2017; cost of goods sold decreased Infinity times to 0.00 thousand RUB from 12.87 million RUB; sales loss made up 1.42 million RUB compared to sales profit of 9.76 million RUB.

2017

Net profit (RAS) of DIALOGFARMA, OOO grew over 2017 4.07 times to 10.19 million RUB from 2.51 million RUB over 2016, the company informed.

Revenue decreased in the accounting period 26.38 times to 37.88 million RUB from 999.29 million RUB in 2016; cost of goods sold decreased 76.04 times to 12.87 million RUB from 978.56 million RUB; sales profit went up 15.30 times to 9.76 million RUB from 638.00 thousand RUB.

2016

Net profit (RAS) of DIALOGFARMA, OOO made up 2.51 million RUB over 2016 compared to net loss of 3.60 million RUB over 2015, the company informed.

Revenue increased in the accounting period by 28.22% to 999.29 million RUB from 779.33 million RUB over 2015; cost of goods sold grew by 28.22% to 978.56 million RUB from 763.22 million RUB; sales profit made up 638.00 thousand RUB compared to sales loss of 7.72 million RUB.

Financial Highlights

Revenue and earnings data

Daily subscription $39 (€32)

unlimited access to database "Kontragent"

download any information within 24 hours

Pay online

Companies in the region

Guarantees

We guarantee

provision of
relevant
information

Payment methods

Statistics

Companies

12 300 159

Reports

17 430 675

Rrocessed requests

Extract from EGRUL:

Today, 12:39 PM

Accounting reports:

Today, 12:40 PM